Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Dec;81(12):e242.
doi: 10.1136/annrheumdis-2020-218983. Epub 2020 Oct 1.

Response to: 'Correspondence on 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis'' by Jeny et al

Andrea Hermina Györfi  1 , Georg Schett  1 , Jörg H W Distler  2
Affiliations
Comment

Response to: 'Correspondence on 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis'' by Jeny et al

Andrea Hermina Györfi et al. Ann Rheum Dis. 2022 Dec.
No abstract available

Keywords: biological therapy; glucocorticoids; sarcoidosis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: JHWD is involved in the development of new targeted therapies for fibrotic diseases such as systemic sclerosis. JHWD has consultancy relationships with Actelion, Active Biotech, Anamar, ARXX, Bayer Pharma, Boehringer Ingelheim, Celgene, Galapagos, GSK, Inventiva, JB Therapeutics, Medac, Pfizer, RuiYi and UCB. JHWD has received research funding from Anamar, Active Biotech, Array Biopharma, aTyr, BMS, Bayer Pharma, Boehringer Ingelheim, Celgene, Galapagos, GSK, Inventiva, Novartis, Sanofi-Aventis, RedX and UCB. JHWD is stock owner of 4D Science and Scientific head of FibroCure.

Comment on

  • Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis.
    Györfi AH, Kopp M, May M, Vetter M, Uder M, Kremer AE, Schett G, Harrer T, Distler JHW. Györfi AH, et al. Ann Rheum Dis. 2021 Jun;80(6):e87. doi: 10.1136/annrheumdis-2020-218258. Epub 2020 Jun 30. Ann Rheum Dis. 2021. PMID: 32606044 No abstract available.
  • Correspondence on 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis'.
    Jeny F, Lhote R, Lorillon G, Belhomme N, Pugnet G, Borie R, Justet A, Jouneau S, Freymond N, Mekinian A, Dhote R, Tandjaoui-Lambiotte Y, Saindenberg N, Gazengel P, Hervier B, Haroche J, Mathian A, Hié M, Chazal T, Taieb D, Uzunhan Y, Le Pavec J, Annesi-Maesano I, Bergot E, Tazi A, Amoura Z, Valeyre D, Nunes H, Cohen-Aubart F. Jeny F, et al. Ann Rheum Dis. 2022 Dec;81(12):e241. doi: 10.1136/annrheumdis-2020-218957. Epub 2020 Oct 1. Ann Rheum Dis. 2022. PMID: 33004334 No abstract available.

Substances